Biolase Technology, Inc. (BLTI) Reports Q3 Loss of 1c Sales Fall Slightly Short
Tweet
Share
E-mailGet Alerts BLTI Hot Sheet
Price: $2.42 +2.54%
Financial Fact:
Income tax provision: 40K
Today's EPS Names:
DGICA, UXIN, TOWN, More
Financial Fact:
Income tax provision: 40K
Today's EPS Names:
DGICA, UXIN, TOWN, More
Join SI Premium – FREE
Biolase Technology, Inc. (NASDAQ: BLTI) reported Q3 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $13.48 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- Altria (MO) delivers in-line earnings, revenue in Q1; shares slightly up
- Expro Group Holdings N.V. (XPRO) Reports In-Line Q1 EPS, provides guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
